Clinical studies for Cognixion’s Axon-R, a brain-computer interface (BCI) intended to help individuals with severe paralysis regain communication, have formally started. IEEE.org claims that this non-invasive technique has a lot of promise for assisting sufferers in regaining their expressive abilities.
Axon-R doesn’t require brain surgery like more invasive BCIs do. Rather, it uses EEG sensors applied to the scalp to read electrical activity from the occipital lobe of the brain. This is especially helpful for those with locked-in syndrome or Amyotrophic Lateral Sclerosis (ALS) since it enables users to manage a computer interface without moving physically.
In the expanding BCI landscape, Axon-R takes a different approach than Elon Musk’s Neuralink, which requires an implanted microchip. While Neuralink has allowed patients to play games using their minds, and Synchron Switch enables messaging via brain signals, Cognixion’s solution is completely external. It joins other non-invasive efforts like Precision Neuroscience, founded by a former Neuralink co-founder.
Axon-R continuously tracks brain responses multiple times per second and uses machine learning to predict user intent. The system presents possible choices in an augmented reality (AR) interface, allowing users to refine their selections naturally. Personalized AI models adapt to the user’s communication style, ensuring more accurate and conversational interactions—without the frustrating autocorrect mishaps.
One of Axon-R’s biggest advantages is that it doesn’t rely on eye movement for control. Many existing assistive technologies require users to look at specific options, making them ineffective for patients with advanced ALS, who may eventually lose even eye movement. Axon-R, however, only requires focused attention, making it a game-changer for those who previously had no means of communication.
For many, the ability to ask for help, express emotions, or connect with loved ones is something easily taken for granted. Cognixion’s Axon-R aims to restore this fundamental human experience, proving that AI, machine learning, and AR can be powerful tools for accessibility.
With clinical trials underway, the future of non-invasive BCIs looks promising—not just for medical applications but potentially for gaming and consumer technology as well.